- All cancer types
- Brain tumor
- Breast cancer
- Cervical cancer
- Childhood cancer
- Colon cancer
- Endometrial cancer
- Kidney cancer
- Lung cancer
- Multiple myeloma
- Ovarian cancer
- Pancreatic cancer
- Prostate cancer
- Skin cancer
- Stomach cancer
- Testicular cancer
Blog: Scientific committee
An expert answers our questions on targeted treatments for kidney cancer
Dr Ekaterini Boleti is a medical oncologist at the Royal Free Hospital in London, United Kingdom. She is an acknowledged expert on renal cancer, with a particular focus on novel treatments including immunotherapy and targeted therapies.
Promising results in immunotherapy
Professor Håkan Mellstedt is a medical oncologist at the Cancer Center Karolinska in Sweden, with extensive clinical and academic experience. In this article, Prof. Mellstedt, also a member of our Scientific Committee, explains the basics of immunotherapy and key research being conducted across cancer types.
Colon cancer: treatment options, genetic testing and biomarkers
Colon cancer is one of the most common types of cancer. We asked Professor Hans-Joachim Schmoll, a member of the CareAcross Scientific Committee and a very experienced medical oncologist a few questions on treatment options, genetic testing and biomarkers.
Multiple Myeloma: genetics and treatment options
Professor Heinz Ludwig, member of the CareAcross Scientific Committee, is an expert in multiple myeloma, based in Austria. During our interview with him, he answered a few questions on the latest developments that are important for all multiple myeloma patients.
A world expert in lung cancer research answers our questions
Federico Cappuzzo is an expert in personalized treatment for lung cancer. We recently asked him to address important issues for patients’ lung cancer screening and treatment.
Targeted lung cancer treatment: interview with world-renowned expert
Targeted therapy is a new development in oncology, which attacks cancer cells but does less damage to normal cells. Professor Tony Mok, a member of the CareAcross Scientific Committee, is an expert in targeted treatments for lung cancer. In this article, he answers 4 important questions relevant to anyone affected by lung cancer.
Interview with Dr Enriqueta Felip on Lung Cancer
Dr. Enriqueta Felip, member of the CareAcross Scientific Committee, is a renowned expert in lung cancer. She holds a PhD in Medical Oncology, and has broad experience in cancer research as well as clinical practice. We recently asked her a few questions on lung cancer, and here are her responses.